Saloner et al. used large-scale cerebrospinal fluid proteomics to uncover molecular signatures in frontotemporal dementia, revealing RNA splicing and synaptic protein candidate markers for genetic and sporadic disease progression.
- Rowan Saloner
- Adam M. Staffaroni
- Kaitlin B. Casaletto